Your browser doesn't support javascript.
loading
The Pin1-CaMKII-AMPA Receptor Axis Regulates Epileptic Susceptibility.
Hou, Xiaojun; Yang, Fan; Li, Angcheng; Zhao, Debao; Ma, Nengjun; Chen, Linying; Lin, Suijin; Lin, Yuanxiang; Wang, Long; Yan, Xingxue; Zheng, Min; Lee, Tae Ho; Zhou, Xiao Zhen; Lu, Kun Ping; Liu, Hekun.
Affiliation
  • Hou X; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
  • Yang F; Fuzhou Children's Hospital of Fujian Medical University, Fuzhou, Fujian, 350005, China.
  • Li A; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
  • Zhao D; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
  • Ma N; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
  • Chen L; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
  • Lin S; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
  • Lin Y; The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350009, China.
  • Wang L; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
  • Yan X; The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, 350009, China.
  • Zheng M; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
  • Lee TH; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
  • Zhou XZ; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
  • Lu KP; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, 350108, China.
  • Liu H; Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02115, USA.
Cereb Cortex ; 31(6): 3082-3095, 2021 05 10.
Article in En | MEDLINE | ID: mdl-33569579
Pin1 is a unique isomerase that regulates protein conformation and function after phosphorylation. Pin1 aberration contributes to some neurological diseases, notably Alzheimer's disease, but its role in epilepsy is not fully understood. We found that Pin1-deficient mice had significantly increased seizure susceptibility in multiple chemical inducing models and developed age-dependent spontaneous epilepsy. Electrophysiologically, Pin1 ablation enhanced excitatory synaptic transmission to prefrontal cortex (PFC) pyramidal neurons without affecting their intrinsic excitability. Biochemically, Pin1 ablation upregulated AMPA receptors and GluA1 phosphorylation by acting on phosphorylated CaMKII. Clinically, Pin1 was decreased significantly, whereas phosphorylated CaMKII and GluA1 were increased in the neocortex of patients with epilepsy. Moreover, Pin1 expression restoration in the PFC of Pin1-deficient mice using viral gene transfer significantly reduced phosphorylated CaMKII and GluA1 and effectively suppressed their seizure susceptibility. Thus, Pin1-CaMKII-AMPA receptors are a novel axis controlling epileptic susceptibility, highlighting attractive new therapeutic strategies.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, AMPA / Genetic Predisposition to Disease / Epilepsy / Calcium-Calmodulin-Dependent Protein Kinase Type 2 / NIMA-Interacting Peptidylprolyl Isomerase Limits: Animals / Humans / Male Language: En Journal: Cereb Cortex Journal subject: CEREBRO Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, AMPA / Genetic Predisposition to Disease / Epilepsy / Calcium-Calmodulin-Dependent Protein Kinase Type 2 / NIMA-Interacting Peptidylprolyl Isomerase Limits: Animals / Humans / Male Language: En Journal: Cereb Cortex Journal subject: CEREBRO Year: 2021 Document type: Article Affiliation country: Country of publication: